Viagra and Pharma: A Risky Investment ?

The story of Viagra presents a tangled case study for pharmaceutical investors . Initially a runaway success, producing billions in profits, the right expiration has exposed the difficulties of relying on a one-off product. While alternative versions have considerably eroded share, questions rema

read more